A Nationally Focused Bioscience Program

Forest City's Science + Technology Group brings to the table a unique set of skills; expertise in the design, development and operation of bioscience buildings, together with a long-term investment perspective, significant financial resources, and a demonstrated ability to work creatively with both corporate and institutional partners. We are one of the country’s leading developers of bioscience properties, meeting the needs of clients ranging from start-ups through mature corporations to major educational and medical institutions.

Our Boston office has a twenty year track record of bringing the worlds of technology and real estate together to provide solutions for organizations involved in advanced research. Examples of this include University Park at MIT, one of the premier centers for biotechnology and medical research in the United States, as well as Forest City’s latest project, a 128,000-square-foot translational research facility currently under development for the University of Pennsylvania and its medical research team, scheduled for completion in October 2004.

Our nationally focused bioscience program includes:

• Bioscience Development, Construction & Operating Expertise 
• Mixed-Use Projects & Urban Campus Environments
• Build-to-Suit Office & Research Facilities 
• Significant Corporate Equity Capital Capacity  
• Innovative Partnering & Financial Structures 
• Long-Term Investment Objective

Forest City also offers a full scope of bioscience asset management and tenant fitout services including:

• Sophisticated base building systems management
• Coordinate and oversee tenant lab facilities
• Facilitate the bioscience permitting process
• Design of high-capacity infrastructure
• Coordinate tenant buildouts and base building designs
• Administration of construction contracts
• Provide substantial funding for tenant buildout

Bioscience Partners & Clients:

• The Massachusetts Institute of Technology
• University of Pennsylvania
• Acambis, Inc.
• Alkermes, Inc.
• Ariad Pharmaceuticals
• Etex Corporation
• Genzyme Biosurgery
• Millennium Pharmaceuticals, Inc.
• Partners HealthCare System